More on CELC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $60.30 |
|
|||
| Open | $60.16 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $60.23 | ||||
| Day Low | $53.54 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,342,459 | ||||
- Form 4 Celcuity Inc. For: Oct 07 Filed by: Furcht Leo
- Form 4 Celcuity Inc. For: Oct 01 Filed by: GRYSKA DAVID W
- Form 3 Celcuity Inc. For: Oct 01 Filed by: GRYSKA DAVID W
- Celcuity to present gedatolisib trial data at ESMO 2026
- Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
- Form 8-K Celcuity Inc. For: Oct 01
- Celcuity adds former Incyte CFO David Gryska to its board
- Celcuity Appoints David Gryska To Its Board Of Directors
- Form 8-K Celcuity Inc. For: Sep 30
- Celcuity's Revtorpyk breast cancer drug now available in the US
Entities mentioned with CELC
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
